BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiati
Go back to BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiati| ATA, Inc. (NASDAQ: ATAI) | Delayed: 5.19 +0.31 (6.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.88 | 52 Week High | $7.32 | |||
| Open | $4.88 | 52 Week Low | $3.30 | |||
| Day High | $5.27 | P/E | N/A | |||
| Day Low | $4.77 | EPS | $0.00 | |||
| Volume | 11,327,766 | |||||
